InMed Pharmaceuticals Inc. SEC filings INM
InMed Pharmaceuticals Inc. has 514 filings in SEC EDGAR's recent list, going back to Jan 17, 2018. Its latest annual report, Form 10-K, was filed on Sep 9, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Sep 9, 2026 | Jun 30, 2026 |
| 10-K/A | Amended annual report | Oct 24, 2025 | Jun 30, 2025 |
| 10-K | Annual report | Sep 23, 2025 | Jun 30, 2025 |
| 10-K | Annual report | Sep 30, 2024 | Jun 30, 2024 |
| 10-K/A | Amended annual report | Dec 21, 2023 | Jun 30, 2023 |
| 10-K | Annual report | Sep 29, 2023 | Jun 30, 2023 |
| 10-K/A | Amended annual report | Sep 28, 2022 | Jun 30, 2022 |
| 10-K | Annual report | Sep 23, 2022 | Jun 30, 2022 |
| 10-K | Annual report | Sep 24, 2021 | Jun 30, 2021 |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INM (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1728328
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.